Cytotoxicity and antitumor activity of the phosphate prodrug of a novel microtubule inhibitor.

被引：0

作者：

Houze, J ^{[1
]}

Gergely, J ^{[1
]}

Schwendner, S ^{[1
]}

Hoffman, L ^{[1
]}

Beckmann, H ^{[1
]}

Baichwal, V ^{[1
]}

Roche, D ^{[1
]}

Jaen, J ^{[1
]}

机构：

[1] Tularik Inc, S San Francisco, CA 94080 USA

来源：

CLINICAL CANCER RESEARCH | 1999年 / 5卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

635

引用

页码：3857S / 3857S

页数：1

共 50 条

[11] Antitumour activity of XR5944, a novel topoisomerase inhibitor.
Stewart, AJ
Dangerfield, W
Lancashire, H
Mistry, P
Okiji, S
Baguley, BD
Denny, WA
Templeton, D
Charlton, P
CLINICAL CANCER RESEARCH, 1999, 5 : 3864S - 3864S
[12] Preclinical antitumor activity and mechanisms of action of apricoxib, a clinical COX-2 inhibitor.
Burrows, F.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
[13] BAL101553: An optimized prodrug of the microtubule destabilizer BAL27862 with superior antitumor activity
Pohlmann, Jens
Bachmann, Felix
Schmitt-Hoffmann, Anne
Gebhardt, Klaus
Spickermann, Jochen
Nuoffer, Claude
Biringer, Gerard
O'Reilly, Terence
Pruschy, Martin
Lane, Heidi A.
CANCER RESEARCH, 2011, 71
[14] 5-arylalkynyl-2-benzoyl thiophene: a novel microtubule inhibitor exhibits antitumor activity without neurological toxicity
Zhuang, Yuxin
Yang, Guang
Wu, Shaoyu
Chen, Jianjun
Guo, Jiayin
Quan, Dongling
Zhang, Tingting
Yang, Zichao
Tan, Shaobin
Ji, Yuheng
Chen, Zhipeng
Lv, Lin
AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (01): : 229 - +
[15] ANTITUMOR ACTIVITY OF A NOVEL FGFR INHIBITOR IN INTRAHEPATIC CHOLANGIOCARCINOMA
Raggi, Chiara
Fiaccadori, Karim
Pastore, Mirella
Correnti, Margherita
Piombanti, Benedetta
Forti, Elisa
Navari, Nadia
Abbadessa, Giovanni
Hall, Terence
Destro, Annarita
Di Tommaso, Luca
Roncalli, Massimo
Meng, Fanyin
Glaser, Shannon S.
Rovida, Elisabetta
Peraldo-Neia, Caterina
Olaizola, Paula
Banales, Jesus M.
Gerussi, Alessio
Elvevi, Alessandra
Busset, Michele Droz Dit
Bhoori, Sherrie
Mazzaferro, Vincenzo
Alpini, Gianfranco
Marra, Fabio
Invernizzi, Pietro
HEPATOLOGY, 2019, 70 : 226A - 227A
[16] Preclinical activity of AZD3409, a novel, oral, prenyl transferase inhibitor.
Stephens, TC
Wardleworth, MJ
Matusiak, ZS
Ashton, SE
Hancox, UJ
Bate, M
Ferguson, R
Boyle, T
CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6114S - 6114S
[17] Design, synthesis and antitumor activity study of a gemcitabine prodrug conjugated with a HDAC6 inhibitor
Li, Yongliang
Liu, Yuanpeng
Chen, Yiran
Wang, Kewei
Luan, Yepeng
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 72
[18] Cytotoxicity in vitro and preliminary antitumor activity in vivo of a novel organotin compound
Barbieri, F
Viale, M
Sparatore, F
Favre, A
Cagnoli, M
Bruzzo, C
Novelli, F
Alama, A
ANTICANCER RESEARCH, 2000, 20 (2A) : 977 - 980
[19] Synthesis and antitumor activity of analogs of the novel microtubule stabilizing agent discodermolide.
Kinder, FR
Bair, KW
Chen, WC
Florence, G
Francavilla, C
Geng, P
Gunasekera, S
Lassota, PT
Longley, RE
Palermo, MG
Paterson, I
Pomponi, S
Ramsey, TM
Rogers, L
Sabio, M
Sereinig, N
Sorensen, E
Wang, RM
Wright, A
Guo, Q
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U47 - U47
[20] Design and synthesis of a novel silanediol collagenase inhibitor.
Glekas, A
Sieburth, SM
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U415 - U415

← 1 2 3 4 5 →